DAFNA Capital Management LLC
Top Portfolio Positions
79 positions ·
$382,680,155 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
580,678 | $56,470,935 | 14.76% | |
| STXS |
Stereotaxis, Inc.
Healthcare
|
13,680,554 | $25,172,219 | 6.58% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
978,463 | $20,978,246 | 5.48% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
597,431 | $17,044,706 | 4.45% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
476,740 | $15,884,976 | 4.15% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
250,772 | $14,582,391 | 3.81% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
217,497 | $14,335,227 | 3.75% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
2,418,882 | $13,376,417 | 3.50% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
165,178 | $11,884,557 | 3.11% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
443,829 | $9,586,706 | 2.51% |
Portfolio Trend
25 quarters · across all stocks
Holdings in IMVT
Shares Held
Position Value (USD)
11 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,739,016 | 150,524 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,826,320 | 150,524 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,086,867 | 191,493 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,063,888 | 191,493 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,905,231 | 169,996 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,675,060 | 107,996 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,482,405 | 51,996 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,264,982 | 47,916 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $950,430 | 29,416 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,716,460 | 40,742 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $863,775 | 22,500 | Shares | Sole | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||